Gary W Moore
Overview
Explore the profile of Gary W Moore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Moore G
Methods Mol Biol
. 2023 May;
2663:275-288.
PMID: 37204717
Lupus anticoagulants (LA) rarely affect routine prothrombin time assays because the high phospholipid (PL) content in thromboplastin reagents tends to overwhelm the antibodies. Dilution of thromboplastin to create a dilute...
12.
Moore G
Methods Mol Biol
. 2023 May;
2663:263-274.
PMID: 37204716
Testing for lupus anticoagulants (LA) in the presence of therapeutic anticoagulation is largely discouraged because of the risk of false-positive and false-negative results, although the ability to detect LA in...
13.
Vandevelde A, Gris J, Moore G, Musial J, Zuily S, Wahl D, et al.
J Thromb Haemost
. 2023 Apr;
21(7):1981-1994.
PMID: 37061133
Background: The added value of antiphosphatidylserine/prothrombin antibodies (aPS/PT) in the diagnostic workup of antiphospholipid syndrome (APS) is unclear. Currently, diagnosis of thrombotic APS (TAPS) and obstetric APS (OAPS) requires persistent...
14.
Moore G, Castoldi E, Teruya J, Morishita E, Adcock D
J Thromb Haemost
. 2023 Jan;
21(1):164-174.
PMID: 36695379
Activated protein C resistance (APC-R) due to the single-nucleotide polymorphism factor V Leiden (FVL) is the most common cause of hereditary thrombophilia. It is found predominantly in Caucasians and is...
15.
Adcock D, Moore G, de Lima Montalvao S, Kershaw G, Gosselin R
Semin Thromb Hemost
. 2022 Sep;
49(6):571-579.
PMID: 36055261
Mixing studies have long been in the clinical laboratory armamentarium for investigating unexpected, prolonged activated partial thromboplastin time (aPTT) or prothrombin time (PT). The purpose of the mixing study is...
16.
Vandevelde A, Chayoua W, de Laat B, Moore G, Musial J, Zuily S, et al.
J Thromb Haemost
. 2022 Jun;
20(9):2136-2150.
PMID: 35713971
Background: Diagnosis of antiphospholipid syndrome (APS) requires persistent presence of lupus anticoagulant (LAC), anticardiolipin (aCL) IgG/IgM, or anti-β2 glycoprotein I (aβ2GPI) IgG/IgM antibodies. Other antiphospholipid antibodies (aPL) such as antiphosphatidylserine/prothrombin...
17.
Moore G
Semin Thromb Hemost
. 2022 Jun;
48(6):643-660.
PMID: 35649428
Lupus anticoagulant (LA) is one of the three criteria antiphospholipid antibodies (aPLs) employed in classification, and by default diagnosis, of antiphospholipid syndrome (APS). Detection of LA is not via calibrated...
18.
Acharya M, Zorn K, Simonson M, Bimali M, Moore G, Peng C, et al.
Hered Cancer Clin Pract
. 2022 May;
20(1):19.
PMID: 35606835
Background: Early identification of hereditary cancer risk would save lives, but genetic testing (GT) has been inadequate. We assessed i) trends for hereditary breast and ovarian cancer (HBOC), Lynch syndrome,...
19.
Fisher R, Moore G, Mitchell M, Dai L, Crichton S, Lumlertgul N, et al.
Ann Intensive Care
. 2022 Mar;
12(1):29.
PMID: 35355147
Background: Regional citrate anticoagulation (RCA) is recommended for continuous renal replacement therapy (CRRT). However, filter life varies and premature filter clotting can occur. The aims of this explorative prospective study...
20.
White D, Moore G, Besser M, Macdonald S, Thomas W
Res Pract Thromb Haemost
. 2022 Feb;
6(1):e12648.
PMID: 35106431
Background: The optimal method of detecting a lupus anticoagulant (LA) for patients taking direct factor Xa inhibitor (DFXaI) direct oral anticoagulants (DOACs) remains controversial. Methods include charcoal adsorption of the...